Glucosamine Hydrochloride + Chondroitin Sulfate

Verify with FDA CVM →

29 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
29
Total Reports
2
Deaths Reported
690.0%
Death Rate

Active Ingredients

Glucosamine Hydrochloride + Chondroitin Sulfate

Administration Routes

OralUnknownParenteral

Species Affected

Dog 27
Cat 2

Most Affected Breeds

Retriever - Labrador 8
Corgi (unspecified) 2
Schnauzer - Miniature 2
Collie - Border 2
Beagle 2
Spaniel - King Charles Cavalier 1
Collie (unspecified) 1
Boxer (German Boxer) 1
Cattle Dog - Flanders (Bouvier) 1
Chihuahua 1

Most Reported Reactions

Vomiting 6
Diarrhoea 3
Weight loss 3
Abnormal radiograph finding 2
Emesis 2
Overdose 2
Lack of efficacy (endoparasite) - heartworm 2
Palpable mass NOS 1
Cough 1
Elevated liver enzymes 1
INEFFECTIVE, HEARTWORM LARVAE 1
Lack of efficacy (roundworm) 1

Outcome Breakdown

Outcome Unknown
12 (41.4%)
Recovered/Normal
7 (24.1%)
Ongoing
6 (20.7%)
Recovered with Sequela
2 (6.9%)
Euthanized
2 (6.9%)

Data Summary

Metric Value
Total adverse event reports 29
Reports involving death 2
Case-fatality rate (reported events) 690.0%
Distinct species in reports 2
Distinct breeds in reports 18
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Glucosamine Hydrochloride + Chondroitin Sulfate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 29 adverse event reports referencing Glucosamine Hydrochloride + Chondroitin Sulfate, including 2 reports in which the animal died — a 690.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Glucosamine Hydrochloride + Chondroitin Sulfate. Reported administration routes include Oral, Unknown, Parenteral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Glucosamine Hydrochloride + Chondroitin Sulfate reports are Dog (27 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (8), Corgi (unspecified) (2), Schnauzer - Miniature (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Glucosamine Hydrochloride + Chondroitin Sulfate are Vomiting (6), Diarrhoea (3), Weight loss (3), Abnormal radiograph finding (2). Of the 29 reports with a coded outcome, Outcome Unknown is the leading category at 41.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Glucosamine Hydrochloride + Chondroitin Sulfate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial